Variant report
| Variant | esv3462778 |
|---|---|
| Chromosome Location | chr3:159256694-159258374 |
| allele | n/a |
| Outlinks | Ensembl UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
| No data |
Variant overlapped rSNPs/rCNVs (count:21 , 50 per page) page:
1
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs16830439 | chr3:159256708-159256709 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 2 | rs539435983 | chr3:159256734-159256735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 3 | rs532981199 | chr3:159256753-159256754 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs551684274 | chr3:159256758-159256759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs1489909 | chr3:159256780-159256781 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 6 | rs534049152 | chr3:159256792-159256793 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs555420851 | chr3:159256818-159256819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs116203545 | chr3:159256822-159256823 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs369379307 | chr3:159256850-159256851 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs372889507 | chr3:159256855-159256856 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs537954027 | chr3:159256907-159256908 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs76897343 | chr3:159256985-159256986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs16847208 | chr3:159256987-159256988 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 14 | rs546058005 | chr3:159256988-159256989 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs114286384 | chr3:159256989-159256990 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs144625224 | chr3:159258241-159258242 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 17 | rs549346440 | chr3:159258272-159258273 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 18 | rs561004755 | chr3:159258277-159258278 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs531372424 | chr3:159258313-159258314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs377454062 | chr3:159258319-159258320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs1387693 | chr3:159258371-159258372 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Variant related diseases (count:53)
| Disease | PMID | Source |
|---|---|---|
| Basal cell lymphoma | 17053054 | CNVD |
| Esophageal cancer | 21851588 | CNVD |
| Uveal melanoma | 21693616 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Retinoblastoma | 21504564 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Thoracic aortic aneurysm | 21092924 | CNVD |
| Intellectual disability | 22102821 | CNVD |
| Autism | 22495311 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Squamous cell cancer | 20885788 | CNVD |
| Melanoma | 18172304 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Breast cancer | 22032731 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Neuroblastoma | 17533364 | CNVD |
| Cervical Cancer | 21857958 | CNVD |
| Melanoma | 21693616 | CNVD |
| Lung cancer | 21426551 | CNVD |
| Cancer | 21637783 | CNVD |
| Cervical cancer | 21063398 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Oral cancer | 21386901 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| Cancer | 22065749 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Basal cell lymphoma | 21115979 | CNVD |
| head and neck squamous cell carcinoma | 17671120 | CNVD |
| Hepatocellular carcinoma | 16750200 | CNVD |
| Esophageal squamous carcinoma | 18350619 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Acute lymphoblastic leukemia | 21339820 | CNVD |
| Basal cell lymphoma | 17170743 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Myofibroblastic sarcoma | 19369631 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Non-small cell lung cancer | 19010865 | CNVD |
| abnormal development | 18461090 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Ovarian clear cell carcinoma | 21343371 | CNVD |
| Colorectal cancer | 16272173 | CNVD |
| Prostate cancer | 16547154 | CNVD |
| Breast cancer | 21364760 | CNVD |
| Gastrointestinal stromal cancer | 20818650 | CNVD |
| Breast cancer | 21509527 | CNVD |
| Effusion lymphoma | 18079361 | CNVD |
| Prostate cancer | 16573809 | CNVD |
| Breast cancer | 21785460 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr3:159253600-159257000 | Enhancers | Liver | Liver |
| 2 | chr3:159258200-159259400 | Enhancers | Fetal Brain Male | brain |
